• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.12% Nasdaq Up0.71%

    Hyperion Therapeutics, Inc. (HPTX)

    -NasdaqGS
    45.97 Down 0.11(0.24%) Apr 24, 4:00PM EDT
    |After Hours : 45.97 0.00 (0.00%) Apr 24, 4:19PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 30,806   26,201   37,094   19,483  
    Cost of Revenue3,828  3,043  4,474  2,382  
    Gross Profit 26,978   23,158   32,620   17,101  
    Operating Expenses
    Research Development6,442  7,009  4,047  3,217  
    Selling General and Administrative12,651  12,631  12,069  11,171  
    Non Recurring -  30,201   -   -  
    Others1,157  1,441  1,014  1,014  
    Total Operating Expenses -  51,282   -   -  
    Operating Income or Loss 6,728   (28,124) 15,490   1,699  
    Income from Continuing Operations
    Total Other Income/Expenses Net(78)(150)136  (52)
    Earnings Before Interest And Taxes6,650  (28,274)15,626  1,647  
    Interest Expense255  777  269  300  
    Income Before Tax6,395  (29,051)15,357  1,347  
    Income Tax Expense(704)3,038  (2,119)88  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops7,099  (32,089)17,476  1,259  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 7,099   (32,089) 17,476   1,259  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 7,099   (32,089) 17,476   1,259  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.